Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults

NCT02132299 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria
Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: PfSPZ Vaccine
BIOLOGICAL: Normal Saline (Placebo)
BIOLOGICAL: PfSPZ Challenge

Sponsor

Sanaria Inc.

Collaborators

[object Object]
[object Object]
[object Object]